Literature DB >> 229072

Invasive lobular carcinoma of the breast: incidence and variants.

V Martinez, J G Azzopardi.   

Abstract

The criteria for the separation of invasive lobular and ductal carcinomas are analysed. Lobular tumours account for 14% of invasive cancers in our material. The widely differing figures given in the literature are mainly attributable to intrinsic difficulties of classification. In addition to the classical dissociated-cell patterns with single filing, a tragetoid appearance and related features, variants with trabecular, loose alveolar and tubular features are recognized; a 'solid' variant requires further investigation. The variants either represent better differentiated forms, or in some cases, an 'earlier' phase in the production of the more traditional Indian file formations and dartboard patterns. Focal signet-ring cell differentiation is another newly-recognized feature. The theoretical and practical implications of these variants are considered. The division into invasive lobular and ductal carcinomas is not as easy as most of the literature implies. Five per cent of cases could not be so classified and, in some of these unclassified cases, both ductal and lobular differentiation may be present. In the diagnosis of problem cases, no single parameter proved reliable but a combination of several parameters enables one to make an objective diagnosis in about 95% of cases.

Entities:  

Mesh:

Year:  1979        PMID: 229072     DOI: 10.1111/j.1365-2559.1979.tb03029.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  58 in total

1.  Sacrificial Bioprinting of a Mammary Ductal Carcinoma Model.

Authors:  Margaux Duchamp; Tingting Liu; Anne M van Genderen; Vanessa Kappings; Rahmi Oklu; Leif W Ellisen; Yu Shrike Zhang
Journal:  Biotechnol J       Date:  2019-05-27       Impact factor: 4.677

2.  Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma.

Authors:  Lan Cao; Ahmed Basudan; Matthew J Sikora; Amir Bahreini; Nilgun Tasdemir; Kevin M Levine; Rachel C Jankowitz; Priscilla F McAuliffe; David Dabbs; Sue Haupt; Ygal Haupt; Peter C Lucas; Adrian V Lee; Steffi Oesterreich; Jennifer M Atkinson
Journal:  Cancer Lett       Date:  2019-06-20       Impact factor: 8.679

3.  Pathology reporting in breast cancer screening. Royal College of Pathologists Working Group.

Authors: 
Journal:  J Clin Pathol       Date:  1991-09       Impact factor: 3.411

4.  Infiltrating lobular carcinoma of the breast.

Authors:  A Howell; M Harris
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-16

5.  Signet Ring Carcinoma of the Breast : An Uncommon Type of Breast Carcinoma.

Authors:  V Srinivas; H Subramanya; T Rajaram; P J Vincent; Ramji Rai
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma.

Authors:  Sonia Narendra; Sarah M Jenkins; Andras Khoor; Aziza Nassar
Journal:  Ann Diagn Pathol       Date:  2015-01-22       Impact factor: 2.090

7.  Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms.

Authors:  Koen Schipper; Anne Paulien Drenth; Eline van der Burg; Samuel Cornelissen; Sjoerd Klarenbeek; Micha Nethe; Jos Jonkers
Journal:  Cancer Res       Date:  2020-02-14       Impact factor: 12.701

8.  Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features.

Authors:  Purevsuren Jambal; Melanie M Badtke; J Chuck Harrell; Virginia F Borges; Miriam D Post; Grace E Sollender; Monique A Spillman; Kathryn B Horwitz; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2012-12-18       Impact factor: 4.872

9.  The diffuse type of invasive lobular carcinoma of the breast: morphology and prognosis.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2003-08-22       Impact factor: 4.064

10.  Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17.

Authors:  Natalya Khilko; Jianmin Wang; Bing Wei; David G Hicks; Ping Tang
Journal:  Breast Cancer (Auckl)       Date:  2010-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.